CenterBook Partners’s Cellebrite CLBT Stock Holding History

CenterBook Partners’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.07M	Sell	95,126 -140,400	-60%	-$1.87M	0.05%	429
2026 Q2	$3.44M	Buy	235,526 +57,020	+32%	+$754K	0.17%	142
2026 Q1	$2.46M	Buy	+178,506	New	+$2.69M	0.13%	196
2025 Q1	–	Sell	-13,720	Closed	-$302K	–	490
2024 Q4	$302K	Sell	13,720 -14	-0.1%	-$269	0.02%	451
2024 Q3	$231K	Sell	13,734 -283,935	-95%	-$4.21M	0.01%	433
2024 Q2	$3.56M	Sell	297,669 -445,172	-60%	-$4.97M	0.22%	180
2024 Q1	$8.23M	Buy	+742,841	New	+$7.58M	0.57%	35

Other funds holding CLBT

True Wind Capital Management San Francisco, California $156M AUM 31.3% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Central Securities New York $1.39B AUM 16.6% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.3B AUM 19.37% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $809M AUM 17.64% 1-Year Est. Return

CenterBook Partners's CLBT Position: Q3 2026 in Review

CenterBook Partners reduced its Cellebrite (CLBT) stake by 60% in Q3 2026, selling an estimated $1.87M and leaving 95,126 shares worth $1.07M. The position accounts for 0.05% of the portfolio, ranked #429.

CenterBook Partners first reported a position in CLBT in Q1 2024 and has held it in 7 quarters since. The position peaked at $8.23M in Q1 2024. 70 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

CenterBook Partners held 95,126 shares of Cellebrite worth $1.07M as of Q3 2026.
CenterBook Partners sold 140,400 Cellebrite shares in Q3 2026, an estimated $1.87M.
Cellebrite made up 0.05% of CenterBook Partners's portfolio in Q3 2026, its #429 holding.
CenterBook Partners first reported a position in Cellebrite in Q1 2024 and has held it in 7 quarters since.
CenterBook Partners's Cellebrite position peaked at $8.23M in Q1 2024.
70 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.